Cannabix Technologies (OTCMKTS:BLOZF) Trading Down 1.2% - Should You Sell?

Key Points

• Shares fell 1.2%, last trading at $0.5392 with an intraday low of $0.5263 and volume of 31,497 shares—about a 69% decline from the average session volume.
• Cannabix develops biosensor technologies and markets a handheld breathalyzer designed to detect recent THC use within minutes for law enforcement, public safety, and workplace screening.
• The company has a market cap of $66.04 million, is currently loss-making (P/E -26.96), and the stock sits above its 50-day ($0.50) and 200-day ($0.44) simple moving averages.

Cannabix Technologies Inc. (OTCMKTS:BLOZF - Get Free Report) shares fell 1.2% during trading on Thursday . The company traded as low as $0.5263 and last traded at $0.5392. 31,497 shares were traded during trading, a decline of 69% from the average session volume of 102,528 shares. The stock had previously closed at $0.5455.

Cannabix Technologies Trading Down 1.2%

The stock has a 50-day simple moving average of $0.50 and a 200 day simple moving average of $0.44. The company has a market cap of $66.04 million, a price-to-earnings ratio of -26.96 and a beta of 1.03.

About Cannabix Technologies

Cannabix Technologies Inc is a Canada-based developer of bio­sensor technologies focused on the rapid, non-invasive detection of cannabis impairment. The company's flagship product is a handheld breathalyzer device designed to identify recent use of tetrahydrocannabinol (THC) within minutes of exhalation, offering law enforcement agencies, public safety organizations and workplace safety departments a potential tool to assess impairment in real time.

The Cannabix breathalyzer employs proprietary sensor arrays and on-board algorithms to distinguish THC molecules in breath samples, delivering results without the need for laboratory analysis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.